1. Role of high mobility group A1 and body mass index in the prognosis of patients with breast cancer.
- Author
-
SHIZHEN ZHANG, RUI LEI, JINGJING WU, JINLAN SHAN, ZUJIAN HU, LIRONG CHEN, XINGCHANG REN, LIFANG YAO, JIAN WANG, and XIAOCHEN WANG
- Subjects
HIGH mobility group proteins ,BODY mass index ,BREAST cancer prognosis ,CANCER-related mortality ,PROTEIN expression - Abstract
The high mobility group A1 (HMGA1) protein is associated with poor prognosis in patients with a wide range of cancers. However, the affect of HMGA1 on the risk of mortality from breast cancer (BC) has not been fully characterized. In the present retrospective multiple center study, the HMGA1 expression level was determined by performing immunohistochemistry on surgical tissue samples of 273 BC specimens from the Second Affiliated Hospital of Zhejiang University (Zhejiang, China) and 310 BCs from the National Engineering Center for Biochip (Shanghai, China). Kaplan-Meier analysis and Cox proportional hazard model were employed to analyze the survivability. HMGA1 expression was significantly associated with tumor histological degree and body mass index (BMI). However, HMGA1 expression showed no prognostic value in patients with BC. Combined evaluation of HMGA1 expression and high BMI (≥24 kg/m2) predicted worse overall survival of BC. Therefore, HMGA1 and BMI were considered to serve synergistic roles in the development and progression of BC, and combined evaluation of HMGA1 expression and high BMI may be an effective marker in predicting poor prognosis of BC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF